DSpace Repository

Design and Evaluation of Transdermal Drug Delivery System of Nebivolol Hydrochloride

Show simple item record

dc.contributor.author Garala, K.
dc.contributor.author Kapadiya, M.
dc.contributor.author Patel, J.
dc.contributor.author Patel, A.
dc.contributor.author Raval, M.
dc.contributor.author Dharamsi, A.
dc.date.accessioned 2023-05-27T07:14:42Z
dc.date.available 2023-05-27T07:14:42Z
dc.date.issued 2013
dc.identifier.citation Garala K, Kapadiya M, Patel J, Patel A, Raval M, Dharamsi A. Design and Evaluation of Transdermal Drug Delivery System of Nebivolol Hydrochloride. Inventi Impact: NDDS, 2013(1):77-91, 2013. en_US
dc.identifier.issn 2229-4147
dc.identifier.uri http://10.9.150.37:8080/dspace//handle/atmiyauni/1138
dc.description.abstract Nebivolol hydrochloride is a selective β1-receptor antagonist with antihypertensive properties having plasma half life of 10 h and 12 % oral bioavailability. In the present work transdermal matrix patches of Nebivolol hydrochloride were prepared to improve its therapeutic efficacy and to avoid its extensive hepatic first pass metabolism of the drug. Nine formulations using 32 full factorial design (composed of Hydroxypropyl methyl cellulose K15M and Eudragit RL100 at a ratios of 1: 1) containing 15% w/w triethyl citrate as plasticizer were prepared. HPMC K15M and Eudragit RL100 were taken as independent variables. Folding endurance, % moisture content, tensile strength, in vitro drug release and flux were taken as dependent variables. Compatibility between drug and polymer was accessed by Fourier transform infrared spectroscopy (FTIR). The prepared TDDSs were evaluated for physicochemical parameters and in vitro skin permeation. F7 formulation exhibit maximum drug release of 99.53% for 24 h due to its higher amount of hydrophobic polymer concentration. Formulation F5 was optimized on the basis of results of dependent variables. The short term accelerated stability study was carried out for the optimized formulation and results revealed that all dependent variables and other parameters were within acceptable limits. Skin irritation study on albino rats have not shown any sign of erythema or edema. Result of high f2 value showed similarity between in vitro drug release profile of reference and test formulation of before and after stability period. Thus, the prepared matrix transdermal film may prove to be a potential candidate to provide sustained drug release for 24 h. en_US
dc.language.iso en en_US
dc.publisher Inventi Journals en_US
dc.title Design and Evaluation of Transdermal Drug Delivery System of Nebivolol Hydrochloride en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account